Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
Clinical trial NCT05292638 · COMPLETED
Trial details
- NCT number
- NCT05292638
- Sponsor
- CKD Bio Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2022-06-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.